BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 26861253)

  • 1. Addressing inherited predisposition for breast cancer in transplant recipients.
    Yang RL; Kurian AW; Winton LM; Weill D; Patel K; Kingham K; Wapnir IL
    J Surg Oncol; 2016 May; 113(6):605-8. PubMed ID: 26861253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary breast cancer: an update on risk assessment and genetic testing in 2015.
    Stuckey AR; Onstad MA
    Am J Obstet Gynecol; 2015 Aug; 213(2):161-5. PubMed ID: 25747548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of genetic testing for BRCA1 and BRCA2 mutations in Austria.
    Singer CF; Muhr D; Rappaport C; Tea MK; Gschwantler-Kaulich D; Fink-Retter A; Pfeiler G; Berger A; Sun P; Narod SA
    Clin Genet; 2014 Jan; 85(1):72-5. PubMed ID: 23772696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health care provider recommendations for reducing cancer risks among women with a BRCA1 or BRCA2 mutation.
    Metcalfe KA; Kim-Sing C; Ghadirian P; Sun P; Narod SA
    Clin Genet; 2014 Jan; 85(1):21-30. PubMed ID: 23859469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing central venous obstruction in cystic fibrosis recipients--lung transplant considerations.
    Otani S; Westall GP; Levvey BJ; Marasco S; Lyon S; Snell GI
    J Cyst Fibros; 2015 Mar; 14(2):255-61. PubMed ID: 25174332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-hole oesophagectomy following bilateral lung transplant for cystic fibrosis.
    Hilzenrat RA; Yee J
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35288429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of lung allocation score on survival in cystic fibrosis lung transplant recipients.
    Braun AT; Dasenbrook EC; Shah AS; Orens JB; Merlo CA
    J Heart Lung Transplant; 2015 Nov; 34(11):1436-41. PubMed ID: 26212659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy in cystic fibrosis lung transplant recipients: case series and review.
    Gyi KM; Hodson ME; Yacoub MY
    J Cyst Fibros; 2006 Aug; 5(3):171-5. PubMed ID: 16797257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond BRCA1 and BRCA2.
    King-Spohn K; Pilarski R
    Curr Probl Cancer; 2014; 38(6):235-48. PubMed ID: 25497410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary breast/ovarian cancer syndrome: a primer for obstetricians/gynecologists.
    Meaney-Delman D; Bellcross CA
    Obstet Gynecol Clin North Am; 2013 Sep; 40(3):475-512. PubMed ID: 24021253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Cancer Prevention: From Mammogram Screening to Identification of BRCA1/2 Mutation Carriers in Underserved Populations.
    Robinson LS; Hendrix A; Xie XJ; Yan J; Pirzadeh-Miller S; Pritzlaff M; Read P; Pass S; Euhus D; Ross TS
    EBioMedicine; 2015 Nov; 2(11):1827-33. PubMed ID: 26870808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colon cancer in lung transplant recipients with CF: increased risk and results of screening.
    Meyer KC; Francois ML; Thomas HK; Radford KL; Hawes DS; Mack TL; Cornwell RD; Maloney JD; De Oliveira NC
    J Cyst Fibros; 2011 Sep; 10(5):366-9. PubMed ID: 21664882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience of risk-reducing salpingo-oophorectomy for a BRCA1 mutation carrier and establishment of a system performing a preventive surgery for hereditary breast and ovarian cancer syndrome in Japan: our challenges for the future.
    Hirasawa A; Masuda K; Akahane T; Tsuruta T; Banno K; Makita K; Susumu N; Jinno H; Kitagawa Y; Sugano K; Kosaki K; Aoki D
    Jpn J Clin Oncol; 2013 May; 43(5):515-9. PubMed ID: 23487443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetical aspects of surgical treatment in patients with hereditary breast cancer].
    Bit-Sava EM
    Vestn Khir Im I I Grek; 2014; 173(5):27-30. PubMed ID: 25823331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of sinus surgery on pseudomonal airway colonization, bronchiolitis obliterans syndrome and survival in cystic fibrosis lung transplant recipients.
    Vital D; Hofer M; Benden C; Holzmann D; Boehler A
    Respiration; 2013; 86(1):25-31. PubMed ID: 22922656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium abscessus chest wall and pulmonary infection in a cystic fibrosis lung transplant recipient.
    Taylor JL; Palmer SM
    J Heart Lung Transplant; 2006 Aug; 25(8):985-8. PubMed ID: 16890122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nipple-sparing mastectomy in patients with BRCA1/2 mutations and variants of uncertain significance.
    Manning AT; Wood C; Eaton A; Stempel M; Capko D; Pusic A; Morrow M; Sacchini V
    Br J Surg; 2015 Oct; 102(11):1354-9. PubMed ID: 26313374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The frequency and outcome of breast cancer risk-reducing surgery in Finnish BRCA1 and BRCA2 mutation carriers.
    Koskenvuo L; Svarvar C; Suominen S; Aittomäki K; Jahkola T
    Scand J Surg; 2014 Mar; 103(1):34-40. PubMed ID: 24177987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung transplantation for cystic fibrosis: 6-year follow-up.
    Quattrucci S; Rolla M; Cimino G; Bertasi S; Cingolani S; Scalercio F; Venuta F; Midulla F
    J Cyst Fibros; 2005 May; 4(2):107-14. PubMed ID: 15914093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.